SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-059226
Filing Date
2020-03-02
Accepted
2020-03-02 17:28:05
Documents
3
Period of Report
2020-02-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d895217d8k.htm 8-K 24514
2 EX-99.1 d895217dex991.htm EX-99.1 12246
3 GRAPHIC g895217g0303013817896.jpg GRAPHIC 2579
  Complete submission text file 0001193125-20-059226.txt   41884
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 20678516
SIC: 2834 Pharmaceutical Preparations